BANK OF AMERICA CORP /DE/ - SIGILON THERAPEUTICS INC ownership

SIGILON THERAPEUTICS INC's ticker is SGTX and the CUSIP is 82657L107. A total of 38 filers reported holding SIGILON THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of SIGILON THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$8,251
+165.2%
8,872
-0.2%
0.00%
Q4 2022$3,111
-37.8%
8,889
-1.7%
0.00%
Q3 2022$5,000
-37.5%
9,042
-7.0%
0.00%
Q2 2022$8,000
-72.4%
9,725
-50.0%
0.00%
Q1 2022$29,000
-59.7%
19,440
-26.1%
0.00%
Q4 2021$72,000
-39.0%
26,290
+25.4%
0.00%
Q3 2021$118,000
-13.9%
20,973
+63.9%
0.00%
Q2 2021$137,000
+1.5%
12,798
+111.9%
0.00%
Q1 2021$135,0006,0400.00%
Other shareholders
SIGILON THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
HARBOURVEST PARTNERS LLC 740,740$35,578,00013.90%
Flagship Pioneering Inc. 10,370,369$498,089,0009.07%
Monashee Investment Management LLC 561,628$26,975,0003.56%
SPHERA FUNDS MANAGEMENT LTD. 567,460$26,061,0002.31%
Avidity Partners Management LP 688,000$33,045,0001.07%
SECTORAL ASSET MANAGEMENT INC 225,000$10,807,0000.76%
Artal Group S.A. 276,000$13,256,0000.28%
GILDER GAGNON HOWE & CO LLC 662,227$31,807,0000.16%
CANADA PENSION PLAN INVESTMENT BOARD 1,485,185$71,333,0000.11%
Perceptive Advisors 125,000$6,004,0000.06%
View complete list of SIGILON THERAPEUTICS INC shareholders